JP2011529959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529959A5 JP2011529959A5 JP2011521666A JP2011521666A JP2011529959A5 JP 2011529959 A5 JP2011529959 A5 JP 2011529959A5 JP 2011521666 A JP2011521666 A JP 2011521666A JP 2011521666 A JP2011521666 A JP 2011521666A JP 2011529959 A5 JP2011529959 A5 JP 2011529959A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- het
- oxo
- diazocan
- chlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 17
- -1 6-oxo-1,6-dihydropyridazin-3-yl Chemical group 0.000 claims 15
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 239000012453 solvate Substances 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 6
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 5
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 claims 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 206010057671 Female sexual dysfunction Diseases 0.000 claims 1
- 206010057672 Male sexual dysfunction Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 claims 1
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 claims 1
- YRACHDVMKITFAZ-UHFFFAOYSA-N [1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC=NN2C=NN=C21 YRACHDVMKITFAZ-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000008484 agonism Effects 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- YAXZJQLARJTMSP-GPTJOGTASA-N methyl 8-(4-chlorophenyl)-4-[(3s,4r)-4-(2-fluoro-4-methoxyphenyl)-1-(6-oxo-1h-pyridazin-3-yl)pyrrolidine-3-carbonyl]-1,4-diazocane-1-carboxylate Chemical compound COC(=O)N1CCN(C(=O)[C@H]2[C@@H](CN(C2)C2=NNC(=O)C=C2)C=2C(=CC(OC)=CC=2)F)CCCC1C1=CC=C(Cl)C=C1 YAXZJQLARJTMSP-GPTJOGTASA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8653008P | 2008-08-06 | 2008-08-06 | |
| US61/086,530 | 2008-08-06 | ||
| PCT/IB2009/053317 WO2010015972A1 (en) | 2008-08-06 | 2009-07-30 | Diazepine and diazocane compounds as mc4 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011529959A JP2011529959A (ja) | 2011-12-15 |
| JP2011529959A5 true JP2011529959A5 (cg-RX-API-DMAC7.html) | 2012-09-06 |
| JP5530438B2 JP5530438B2 (ja) | 2014-06-25 |
Family
ID=41226202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011521666A Expired - Fee Related JP5530438B2 (ja) | 2008-08-06 | 2009-07-30 | Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8592403B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2326638B9 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5530438B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101280786B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102171206B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009278838B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2731897C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2326638T5 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2421920T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL210703A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011001405A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010015972A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201100374B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2512778Y2 (ja) | 1990-06-19 | 1996-10-02 | 株式会社荏原製作所 | 全速待機運転ポンプ |
| AU2007219236B2 (en) | 2006-02-23 | 2012-06-21 | Pfizer Limited | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| CN102464623B (zh) * | 2010-11-19 | 2015-04-29 | 上海药明康德新药开发有限公司 | 1,4-二氮杂环辛烷-6-甲酸酯衍生物的制备方法 |
| PT3539551T (pt) | 2011-12-29 | 2021-11-04 | Rhythm Pharmaceuticals Inc | Método de tratamento de distúrbios associados ao recetor de melanocortina-4 em portadores heterozigóticos |
| MX373722B (es) * | 2013-04-11 | 2020-04-13 | Ctc Bio Inc | Forma farmaceutica en pelicula que contiene tadalafilo en forma de base libre con polimero de polietilenglicol y/o polimero de vinil pirrolidona como estabilizante de dispersion. |
| US11116769B2 (en) * | 2013-04-11 | 2021-09-14 | Ctc Bio, Inc. | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
| RU2731913C2 (ru) | 2015-08-04 | 2020-09-09 | Астеллас Фарма Инк. | Пиперазиновое производное |
| AU2016330773A1 (en) | 2015-09-30 | 2018-04-19 | Charité-Universitätsmedizin Berlin | Method of treating melanocortin-4 receptor pathway-associated disorders |
| WO2019195756A1 (en) | 2018-04-06 | 2019-10-10 | Rhythm Pharmaceuticals, Inc. | Compositions for treating kidney disease |
| WO2020087031A1 (en) | 2018-10-26 | 2020-04-30 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH507249A (de) | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| GB8531071D0 (en) | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2098167C (en) | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
| AU675145B2 (en) * | 1993-06-18 | 1997-01-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| TW381025B (en) | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
| US5596106A (en) | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| DE4435477A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| KR100227231B1 (ko) | 1994-10-27 | 1999-11-01 | 디르크 반테 | 아포리포프로테인-b 합성 억제제 |
| US5521186A (en) | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
| WO1997017973A1 (en) * | 1995-11-13 | 1997-05-22 | Smithkline Beecham Corporation | Hemoregulatory compounds |
| CN1228087A (zh) * | 1996-08-14 | 1999-09-08 | 曾尼卡有限公司 | 取代的嘧啶衍生物和它们的药物用途 |
| AU4020897A (en) * | 1996-08-17 | 1998-03-06 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| US5929077A (en) * | 1996-11-08 | 1999-07-27 | Leftheris; Katerina | Thioproline-containing inhibitors of farnesyl protein transferase |
| WO2000035296A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Improved release of medicament active agents from a chewing gum coating |
| IL141769A0 (en) | 1998-09-11 | 2002-03-10 | Aventis Pharma Sa | Azetidine derivatives, preparation and medicines containing them |
| FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| US8273713B2 (en) | 2000-12-14 | 2012-09-25 | Amylin Pharmaceuticals, Llc | Methods of treating obesity using PYY[3-36] |
| PL210793B1 (pl) | 2001-02-28 | 2012-03-30 | Merck & Co Inc | Acylowane pochodne piperydyny |
| AU2002255597B8 (en) | 2001-02-28 | 2006-10-26 | Merck Sharp & Dohme Corp. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| RU2281941C2 (ru) | 2001-03-22 | 2006-08-20 | Солвей Фармасьютикалс Б.В. | Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью |
| JP2005514008A (ja) | 2001-09-24 | 2005-05-19 | オレゴン ヘルス アンド サイエンス ユニバーシティー | 摂食行動を改変する薬剤をスクリーニングするための、弓状核におけるニューロンの評価方法 |
| AU2003219934A1 (en) | 2002-03-06 | 2003-09-22 | Merck And Co., Inc. | Method of treatment or prevention of obesity |
| WO2004013120A1 (en) | 2002-07-29 | 2004-02-12 | F. Hoffmann-La Roche Ag | Novel benzodioxoles |
| ATE375349T1 (de) | 2002-08-02 | 2007-10-15 | Merck & Co Inc | Substituierte furo(2,3-b)pyridin derivate |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| MY134457A (en) | 2002-11-22 | 2007-12-31 | Merck & Co Inc | Substituted amides |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US20050192286A1 (en) * | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
| US7151097B2 (en) | 2003-11-07 | 2006-12-19 | Pfizer Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| ES2303280T3 (es) * | 2004-10-15 | 2008-08-01 | Glaxo Group Limited | Derivados de pirrolidina como ligandos de receptores de histamina. |
| JP5009785B2 (ja) * | 2005-03-25 | 2012-08-22 | キッセイ薬品工業株式会社 | ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途 |
| EP1912968A1 (en) | 2005-08-04 | 2008-04-23 | Pfizer Limited | Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
-
2009
- 2009-07-30 ES ES09786755T patent/ES2421920T3/es active Active
- 2009-07-30 CA CA2731897A patent/CA2731897C/en not_active Expired - Fee Related
- 2009-07-30 JP JP2011521666A patent/JP5530438B2/ja not_active Expired - Fee Related
- 2009-07-30 CN CN200980139321.7A patent/CN102171206B/zh not_active Expired - Fee Related
- 2009-07-30 MX MX2011001405A patent/MX2011001405A/es active IP Right Grant
- 2009-07-30 US US13/057,319 patent/US8592403B2/en not_active Expired - Fee Related
- 2009-07-30 AU AU2009278838A patent/AU2009278838B2/en not_active Ceased
- 2009-07-30 KR KR1020117005275A patent/KR101280786B1/ko not_active Expired - Fee Related
- 2009-07-30 WO PCT/IB2009/053317 patent/WO2010015972A1/en not_active Ceased
- 2009-07-30 EP EP09786755.0A patent/EP2326638B9/en not_active Not-in-force
- 2009-07-30 DK DK09786755.0T patent/DK2326638T5/da active
-
2011
- 2011-01-14 ZA ZA2011/00374A patent/ZA201100374B/en unknown
- 2011-01-17 IL IL210703A patent/IL210703A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011529959A5 (cg-RX-API-DMAC7.html) | ||
| CA2642922A1 (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| AU2013329552B2 (en) | 5-phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors | |
| RU2012136643A (ru) | [5,6]- гетероциклическое соединение | |
| AU2009292931B2 (en) | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | |
| IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| RU2005130020A (ru) | Производные пиразолопиридина | |
| HRP20231310T1 (hr) | Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene | |
| RU2014139601A (ru) | Ингибиторы серин/треониновых киназ | |
| JP2012501312A5 (cg-RX-API-DMAC7.html) | ||
| JP2016519096A5 (cg-RX-API-DMAC7.html) | ||
| JP2007510689A5 (cg-RX-API-DMAC7.html) | ||
| JP2016514718A5 (cg-RX-API-DMAC7.html) | ||
| JP2011503150A5 (cg-RX-API-DMAC7.html) | ||
| JP2019530695A5 (cg-RX-API-DMAC7.html) | ||
| CA2351725A1 (en) | Substituted pyrazoles as p38 kinase inhibitors | |
| JP2014516074A5 (cg-RX-API-DMAC7.html) | ||
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| RU2008126398A (ru) | Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti) | |
| JP2011509937A5 (cg-RX-API-DMAC7.html) | ||
| JP2013539777A5 (cg-RX-API-DMAC7.html) | ||
| RU2009121564A (ru) | Азаадамантановые производные и способы применения | |
| JP2020512343A5 (cg-RX-API-DMAC7.html) | ||
| JP2008525498A5 (cg-RX-API-DMAC7.html) | ||
| RU2008141509A (ru) | Mglur5 модуляторы 1 |